[ad_1]
The public had an opportunity to weigh in with the FDA through July 16. Four days before the deadline, more than 3,000 comments had been published on the public docket. Now that the public comment period is over, the FDA will review the submitted data and anticipates reporting on its progress “around end of summer/early fall.”
[ad_2]
Source link